ANTICOAGULANT SODIUM CITRATE SOLUTION, USP
FRESENIUS KABI CANADA LTD
Quick answers
Is there a shortage of ANTICOAGULANT SODIUM CITRATE SOLUTION, USP in Canada?
No. There is no current shortage of ANTICOAGULANT SODIUM CITRATE SOLUTION, USP 4G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML
BAXTER CORPORATION
ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION, USP
BAXTER CORPORATION
⚠ Possible Recall or Safety Alert
Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.
DIN
02529637
Strength
4G
Dosage Form
SOLUTION
Route
EXTRACORPOREAL 0-UNASSIGNED
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other Products from FRESENIUS KABI CANADA LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
900MG · DIN 02395150
20MG · DIN 02538644
50MG · DIN 02403536
50MG · DIN 02236926
DIN 02497697
3MG · DIN 02267659
3MG · DIN 02457482
3MG · DIN 02457474
50MG · DIN 02245248
500MG · DIN 02227010
2G · DIN 02226995
250MG · DIN 02227029